Bristol-Myers Squibb to Take Part in Credit Suisse 2016 Health Care Conference
Bristol-Myers Squibb Company (NYSE: BMY) will take part in the Credit Suisse Annual Health Care Conference on
Tuesday, November 8, 2016 in Scottsdale, Arizona. Fouad Namouni, senior vice president, Head Oncology Development, will answer
questions about the company at 8 a.m. MT (10 a.m. ET).
Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative
medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us
at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.
###
Bristol-Myers Squibb Company
Media:
Ken Dominski, 609-252-5251
ken.dominski@bms.com
or
Investors:
Tim Power, 609-252-7509
timothy.power@bms.com
or
Bill Szablewski, 609-252-5894
william.szablewski@bms.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20161101006226/en/